Position in ELAN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$110,951,600
+$36,274,088 QoQ
Shares Held
4,508,395
+44.5% QoQ
Ownership
0.902%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#20
of 518 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JENNISON ASSOCIATES LLC holds $137,114,984 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (80.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
This page
|
4,508,395 | $110,951,600 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
359,114 | $12,166,782 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
198,715 | $9,393,257 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
168,863 | $2,923,018 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
28,636 | $1,036,623 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
35,841 | $643,704 |
All Filings in ELAN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,951,600 | 4,508,395 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $74,677,512 | 3,120,665 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $59,436,540 | 2,626,449 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $80,043,347 | 3,974,347 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $46,191,758 | 3,234,717 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $8,049,247 | 766,595 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $13,269,047 | 1,095,710 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $15,872,016 | 1,080,464 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $9,121,144 | 632,096 | Shares | Defined | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||